news/
12 pages · Updated May 17, 2026
Pages
- Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
- Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye
- Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
- Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
- Gene editing pioneers launch first startup focused on custom CRISPR therapies
- JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing
- Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments
- Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines
- Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies
- Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
- Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more
- Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye